Piotroski F-score
Failed
3 checks could not be answered: a figure either filed year needs is missing, not evidence either way.
ACGLN reported revenue of $19.93B and net income of $4.4B in FY2025.
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2025 | $19.93B | $4.4B |
| 2024 | $17.44B | $4.31B |
| 2023 | $13.63B | $4.44B |
15 more years are on Measure
Free, no card, and it does not expire. See what the paid plans add
Also filed under Insurance, ranked by how closely they sit beside ACGLN.
ACGLN is among the largest companies matching:
The assistant answers from what ACGLN has actually filed: 18 annual reports filed with the SEC and 62 Form 4 filings from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Cash flow breakdown
What the business generated, and where it went
Operating cash flow
$6.17B 2025
Cash generated by the business itself
Free cash flow
$6.13B 2025
Operating cash flow minus capital expenditure
Capital expenditure
$44M 2025
Spending on property, plant and equipment
ACGLN generated $6.17B of operating cash flow. Each figure below is what it did with that, as reported on the same statement.
Reinvested in the business
Spent on its own shares
A non-cash cost, added back above
As reported in the company's own annual filings.
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.17B | $6.67B | $5.75B | $3.82B | $3.43B | $2.89B | $2.05B | $1.56B | $1.09B | - | - | - | $850.87M | $921.6M | $866.11M | $802.07M |
Financial statements
Every figure below is this company’s, as filed. Measure draws them: 18 years and 68 quarters plotted to scale, on the income statement, balance sheet and cash flow, plus the ratio and estimate sections this page does not carry.
Free, no card, and it does not expire. See what the paid plans add
As reported in the company's own annual filings.
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.93B | $17.44B | $13.63B | $9.61B | $9.25B | $8.51B | $6.93B | $5.45B | $5.63B | $4.46B | $3.94B | $3.99B | $3.53B | $3.48B | $3.06B | $3.24B |
Total assets
Plotted to scale onMeasure
Total liabilities
Plotted to scale onMeasure
Cash
Plotted to scale onMeasure
As reported in the company's own annual filings.
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $79.24B | $70.91B | $58.91B | $47.99B | $45.1B | $43.28B | $37.89B | $32.22B | $32.05B | $29.37B | $23.14B | $21.97B | $19.56B | $17.82B | $17.11B | $16.28B |
Derived from SEC XBRL filings. Not investment advice.
Press one and the answer appears right here on the page, from ACGLN's filings and figures. One a day without an account; a free account has its own, and no card.
See every filed year for ACGLN, quarter by quarter.
Ten seconds. No card. Nothing to cancel.
Be told the next time ACGLN files
Watch ACGLN and every quarterly and annual report, material 8-K, open-market Form 4 worth a row and tracked manager's change lands in the bell and a daily email. Free.
See all 18 filed years plotted, not just read
Every annual statement ACGLN has filed is on this page as figures. Drawn to scale, a trend over the whole record is something you can see rather than something you have to add up.
The charts, to scaleMeasure
Catch a turn before the year confirms it
Revenue, margins and cash flow quarter by quarter, where a change in direction shows up first.
Quarterly statementsMeasure
Ask why a number moved, get the filing back
Why a margin moved, where the cash went: answered from ACGLN's own statements, not a guess.
Free, no card, and it does not expire.
| $992.65M |
| $1.14B |
| Capital expenditure | $44M | $51M | $52M | $50M | $41M | $39.87M | $37.84M | $29.81M | $22.84M | $15.3M | $15.74M | $19.88M | $17.5M | $18.53M | $18.99M | $11.66M | $19.48M | $9.5M |
|---|
| Free cash flow | $6.13B | $6.62B | $5.7B | $3.77B | $3.38B | $2.85B | $2.01B | $1.53B | $1.07B | - | - | - | $833.37M | $903.07M | $847.13M | $790.41M | $973.16M | $1.13B |
|---|
| Stock-based compensation | $148M | $133M | $93M | $88M | $88M | $71.26M | $66.42M | $55.78M | $67.8M | $56.58M | $56.1M | $54.79M | $49.24M | $42.3M | $30.99M | $31.07M | $27.04M | $30.28M |
|---|
| Buybacks | $1.89B | $24M | $0 | $586M | $1.23B | $83.47M | $2.87M | $282.76M | $0 | $75.26M | $365.38M | $454.14M | $57.8M | $172.06M | $287.56M | $761.87M | $458.4M | $513.13M |
|---|
| $3.5B |
| $2.97B |
| Selling, general and administrative | $132M | $200M | $102M | $95M | $78M | $81.99M | $80.11M | $78.99M | $83.75M | $81.75M | $49.75M | $49.94M | - | - | - | - | - | - |
|---|
| Net income | $4.4B | $4.31B | $4.44B | $1.48B | $2.16B | $1.41B | $1.64B | $757.97M | $619.28M | $692.74M | $537.74M | $834.36M | $709.73M | $593.4M | $436.16M | $842.67M | $876.95M | - |
|---|
| Diluted EPS | $11.60 | $11.19 | $11.62 | $3.80 | $5.23 | $3.32 | $3.87 | $1.73 | $1.36 | $1.78 | $4.09 | $6.02 | $5.07 | $4.03 | $2.97 | $5.18 | $4.58 | $4.09 |
|---|
| Diluted shares | 375.9M | 381.8M | 378.8M | 377.6M | 400.3M | 410.26M | 411.61M | 412.91M | 417.79M | 374.15M | 126.04M | 134.92M | 135.78M | 138.26M | 138.29M | 157.57M | 185.78M | 64.79M |
|---|
| Dividend per share | $5.00 | $5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|---|
| Net margin | 22.07% | 24.72% | 32.59% | 15.35% | 23.32% | 16.52% | 23.63% | 13.91% | 11.00% | 15.52% | 13.66% | 20.92% | 20.13% | 17.04% | 14.24% | 25.98% | 25.04% | - |
|---|
| $15.38B |
| - |
| Cash | $993M | $979M | $917M | $855M | $859M | $906.45M | $726.23M | $646.56M | $606.2M | $842.94M | $553.33M | $485.7M | $434.06M | $371.04M | $351.7M | $362.74M | $334.57M | $251.74M |
|---|
| Short-term investments | - | - | - | - | $1.73B | $1.92B | $956.55M | $955.88M | $1.47B | $612.01M | $587.9M | $797.23M | $1.48B | $722.12M | $904.22M | $915.84M | $571.49M | - |
|---|
| Total liabilities | $55.04B | $50.09B | $40.55B | $35.07B | $31.55B | $29.29B | $25.57B | $21.78B | $21.81B | $20.06B | $16.03B | $14.89B | $13.91B | $12.65B | $12.51B | $11.77B | $11.05B | - |
|---|
| Temporary equity | - | - | - | - | $9M | $58.55M | $55.4M | - | - | - | - | - | - | - | - | - | - | - |
|---|
| Shareholder equity | $24.21B | $20.82B | $18.35B | $12.91B | $13.55B | $13.11B | $11.5B | $9.44B | $9.2B | $8.25B | $6.17B | $6.09B | $5.65B | $5.17B | $4.59B | - | - | - |
|---|